Anavex Life Sciences Corp (AVXL)

[boi568]

I think your explanation of selection bias is an appropriate prologue to Investor's repetitive posts regarding the likely success of any future Phase 3 AD trial (if needed). Anavex has developed a fundamental understanding of subgroup factors that would help assure success. They aren't about to use random variables, or mistaken assumptions, in a selection process; unlike the competition, they have been doing the hard and groundbreaking fundamental research into the mechanisms of Alzheimer's Disease.